Clinical Trials, Research and Development
October 8, 2021
Via: Genetic Engineering and Biotechnology NewsAllogene Therapeutics saw its shares fall more than 40% in early trading Friday after acknowledging that the FDA had placed a clinical hold on its trials evaluating its allogeneic CAR T (AlloCAR T) therapies for cancer. Allogene said the clinical […]
July 19, 2024
July 11, 2024
July 11, 2024